Your Web News in One Place

Help Webnuz

Referal links:

Sign up for GreenGeeks web hosting
June 9, 2021 08:44 pm GMT

Alzheimers is open for business: Controversial FDA approval could pave the way for future drugs

On Monday, a 17-year drought in the world of Alzheimers drugs ended with the FDA approval of Biogens Aduhlem (aducanumab). The controversy behind the FDAs decision was considerable, but it doesnt seem to be spooking drug developers who are now narrowing in on the degenerative brain disease. In a nutshell, the approval of Aduhelm came […]

Original Link: http://feedproxy.google.com/~r/Techcrunch/~3/bPq9oXsHet4/

Share this article:    Share on Facebook
View Full Article

Techcrunch

TechCrunch is a leading technology blog, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news.

More About this Source Visit Techcrunch